Is it normal to experience lingering anxiety 11 days after discontinuing Latuda (lurasidone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, experiencing lingering anxiety 11 days after stopping Latuda is normal and expected

Anxiety symptoms can persist for weeks to months after discontinuing psychotropic medications, including antipsychotics like Latuda, representing either withdrawal effects, return of underlying symptoms, or both. 1

Understanding Post-Discontinuation Anxiety

The anxiety you're experiencing 11 days after stopping Latuda falls into a well-recognized pattern for psychotropic medication discontinuation:

Timeline of Symptom Return

  • Patients with mood and anxiety disorders may experience return of symptoms weeks to months after their last dose of medication 1
  • The monitoring period after discontinuation needs to be extended beyond just days—symptoms can emerge or persist for a prolonged period
  • This is distinct from acute withdrawal, which typically occurs within hours to days

What's Happening Physiologically

Your lingering anxiety could represent:

  1. Protracted withdrawal symptoms: Anxiety is a recognized withdrawal symptom from various psychotropic medications 2. While the evidence primarily discusses opioids and benzodiazepines, the principle applies to antipsychotics—abrupt discontinuation can cause anxiety and depressive symptoms to emerge or intensify 2

  2. Return of underlying symptoms: If Latuda was treating anxiety as part of your condition (bipolar depression, schizophrenia), you may be experiencing a return of the original symptoms 1

  3. Unmasking of baseline anxiety: The medication may have been suppressing anxiety that was present but not fully recognized 2

Clinical Context from Latuda Studies

The FDA label and clinical trials provide important context 3:

  • Anxiety was reported as an adverse effect in 4-7% of patients taking Latuda in clinical trials
  • Lurasidone has demonstrated efficacy in reducing anxiety symptoms in both bipolar depression 4, 5, 6, 7 and schizophrenia 8
  • When effective medication is discontinued, anxiety symptoms that were being controlled can return

What You Should Do

Contact your prescribing physician immediately to discuss your symptoms. The appropriate response depends on:

  • Whether this represents withdrawal that will resolve with time
  • Whether this is a return of your underlying condition requiring treatment
  • Whether you need a gradual taper rather than abrupt discontinuation (if that's what occurred)

Key Monitoring Points

Your physician should assess:

  • Severity and trajectory of anxiety symptoms
  • Other psychiatric symptoms (mood changes, sleep disturbance, agitation)
  • Whether symptoms are worsening, stable, or improving
  • Your functional impairment

Important Caveats

Gradual tapering is generally recommended for psychotropic medications to avoid withdrawal symptoms and rebound worsening of symptoms 1. If you stopped Latuda abruptly rather than through a gradual taper, this increases the likelihood that your anxiety represents discontinuation effects.

The distinction between withdrawal symptoms and return of underlying illness is often difficult to make clinically 2, which is why ongoing monitoring with your prescriber is essential during this period.

Do not attempt to manage this on your own—psychiatric medication discontinuation requires medical supervision to ensure safety and appropriate symptom management 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.